CDH2 and breast cancer: Sd-133 also inhibited MDA-MB-231 matrigelTM outgrowth at 1μM (Figure 5C) but was inactive on control MDA-MB-435 melanoma cells (express N-cadherin) or MCF7 breast cancer cells that express E and P-cadherin (Figure 5D).